Tandem Diabetes Care (TNDM) Shares Outstanding (Weighted Average) (2013 - 2026)
Tandem Diabetes Care posted quarterly Shares Outstanding (Weighted Average) of $68.4 million for Q1 2026, up 3.0% year-on-year from $66.4 million in Q1 2025, and up 35194.76% on a QoQ basis from $193788.0 in Q3 2025.
Tandem Diabetes Care (TNDM) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $68.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.0% year-over-year to $68.4 million; the trailing twelve-month figure through Mar 2026 stood at $68.4 million (up 3.0% YoY), and the FY2024 full-year result was $65.5 million, up 0.74% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $68.4 million, up from $193788.0 in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $68.4 million in Q1 2026 and bottomed at $193788.0 in Q1 2023.
- The 5-year median for Shares Outstanding (Weighted Average) is $64.1 million (2022), against an average of $40.9 million.
- The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) slumped 99.7%; it then jumped 34499.67% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $64.1 million in 2022, then grew by 1.28% to $65.0 million in 2023, then grew by 0.74% to $65.5 million in 2024, then plunged by 99.7% to $193788.0 in 2025, then surged by 35194.76% to $68.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $68.4 million (Q1 2026), $193788.0 (Q3 2025), and $67.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 68.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.40 Mn |
| Sep 30, 2025 | 193,788.00 |
| Jun 30, 2025 | 67.05 Mn |
| Mar 31, 2025 | 66.40 Mn |
| Dec 31, 2024 | 65.45 Mn |
| Sep 30, 2024 | 193,788.00 |
| Jun 30, 2024 | 193,788.00 |
| Mar 31, 2024 | 193,788.00 |
| Dec 31, 2023 | 64.97 Mn |
| Sep 30, 2023 | 193,788.00 |
| Jun 30, 2023 | 64.83 Mn |
| Mar 31, 2023 | 193,788.00 |
| Dec 31, 2022 | 64.15 Mn |
| Sep 30, 2022 | 64.24 Mn |
| Jun 30, 2022 | 64.08 Mn |
| Mar 31, 2022 | 63.88 Mn |
| Dec 31, 2021 | 63.00 Mn |
| Sep 30, 2021 | 62.78 Mn |
| Jun 30, 2021 | 62.58 Mn |
| Mar 31, 2021 | 254,349.00 |
| Dec 31, 2020 | 60.99 Mn |
| Sep 30, 2020 | 60.57 Mn |
| Jun 30, 2020 | 60.08 Mn |
| Mar 31, 2020 | 415,200.00 |
| Dec 31, 2019 | 58.51 Mn |
| Sep 30, 2019 | 58.80 Mn |
| Jun 30, 2019 | 58.00 Mn |
| Mar 31, 2019 | 57.77 Mn |
| Dec 31, 2018 | 48.13 Mn |
| Sep 30, 2018 | 44.99 Mn |
| Jun 30, 2018 | 50.95 Mn |
| Mar 31, 2018 | 17.99 Mn |
| Dec 31, 2017 | 5.68 Mn |
| Sep 30, 2017 | 4.47 Mn |
| Jun 30, 2017 | 4.10 Mn |
| Mar 31, 2017 | 3.19 Mn |
| Dec 31, 2016 | 3.06 Mn |
| Sep 30, 2016 | 3.05 Mn |
| Jun 30, 2016 | 30.39 Mn |
| Mar 31, 2016 | 30.29 Mn |
| Dec 31, 2015 | 2.89 Mn |
| Sep 30, 2015 | 30.04 Mn |
| Jun 30, 2015 | 29.90 Mn |
| Mar 31, 2015 | 25.52 Mn |
| Dec 31, 2014 | 23.27 Mn |
| Sep 30, 2014 | 23.17 Mn |
| Jun 30, 2014 | 23.02 Mn |
| Mar 31, 2014 | 22.94 Mn |
| Dec 31, 2013 | 2.94 Mn |
| Sep 30, 2013 | 210,996.00 |
| Jun 30, 2013 | 211,035.00 |
| Mar 31, 2013 | 207,609.00 |